Hydromorphone HCl prolonged-release tablets (BID, twice daily), (4 mg, 8 mg, 16 mg, 24 mg)
Develco Pharma GmbH
Country
GermanyCity
Schopfheim
Develco Pharma has been engaged in the production and development of medications containing non-brand name active components since 2006. Our proficient team actively explores creative methods for formulating drugs, designing and executing clinical trials, preparing regulatory paperwork, and manufacturing, examining, and packaging intricate dosage forms. Our specialization lies in the delayed or altered release of active ingredients in order to enhance the benefits for patients.
Products & Services
GermanyHydromorphone HCl prolonged-release tablets (OD, once daily) (4 mg, 8 mg, 16 mg, 32 mg)
Develco Pharma GmbH
Country
GermanyCity
Schopfheim
Levomethadon HCl immediate release (IR) tablets (2,5 mg, 5 mg, 7,5 mg, 20 mg, 30 mg)
Develco Pharma GmbH
Country
GermanyCity
Schopfheim
Levomethadon HCl immediate release (IR) tablets (5 mg, 20 mg)
Develco Pharma GmbH
Country
GermanyCity
Schopfheim
Methylphenidate HCl EQ capsules. (10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg)
Develco Pharma GmbH
Country
GermanyCity
Schopfheim
Sites
Develco Pharma GmbH
Audited
Country
GermanyCity
Schopfheim
Silver
2024 Qualifyze Quality Compliance Rating2024 Qualifyze QCR